Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Dec;52(12):862–865. doi: 10.1136/ard.52.12.862

Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.

H R van den Brink 1, A A van Everdingen 1, M J van Wijk 1, J W Jacobs 1, J W Bijlsma 1
PMCID: PMC1005216  PMID: 8311536

Abstract

OBJECTIVE--To investigate whether oestrogens can be used as treatment to diminish disease activity in women with rheumatoid arthritis. METHODS--Forty postmenopausal female patients with active rheumatoid arthritis participated in a placebo-controlled, double-blind study on the possible beneficial effect of adjuvant treatment of oestradiol on disease activity. RESULTS--Thirty three patients completed 52 weeks of treatment with 2 mg oestradiol-valerate or placebo. No statistically significant difference was found in and between both treatment groups with regard to articular indices, pain score by visual analogue scale, erythrocyte sedimentation rate and health questionnaire on daily activities before, during and at the end of the study. CONCLUSION--This first randomised prospective placebo-controlled study shows no beneficial effect of oestrogens on disease activity in postmenopausal female patients with rheumatoid arthritis.

Full text

PDF
862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Bijlsma J. W., Huber-Bruning O., Thijssen J. H. Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis. Ann Rheum Dis. 1987 Oct;46(10):777–779. doi: 10.1136/ard.46.10.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GILBERT M., ROTSTEIN J., CUNNINGHAM C., ESTRIN I., DAVIDSON A., PINCUS G. NORETHYNODREL WITH MESTRANOL IN TREATMENT OF RHEUMATOID ARTHRITIS. JAMA. 1964 Oct 19;190:235–235. doi: 10.1001/jama.1964.03070160059013. [DOI] [PubMed] [Google Scholar]
  4. Goemaere S., Ackerman C., Goethals K., De Keyser F., Van der Straeten C., Verbruggen G., Mielants H., Veys E. M. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol. 1990 Dec;17(12):1620–1622. [PubMed] [Google Scholar]
  5. Goldsmith C. H., Smythe H. A., Helewa A. Interpretation and power of a pooled index. J Rheumatol. 1993 Mar;20(3):575–578. [PubMed] [Google Scholar]
  6. Hazes J. M., Dijkmans B. A., Vandenbroucke J. P., Cats A. Oral contraceptive treatment for rheumatoid arthritis: an open study in 10 female patients. Br J Rheumatol. 1989;28 (Suppl 1):28–30. doi: 10.1093/rheumatology/xxviii.suppl_1.28. [DOI] [PubMed] [Google Scholar]
  7. Holmdahl R., Jansson L., Andersson M. Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum. 1986 Dec;29(12):1501–1509. doi: 10.1002/art.1780291212. [DOI] [PubMed] [Google Scholar]
  8. Latman N. S. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am J Med. 1983 Jun;74(6):957–960. doi: 10.1016/0002-9343(83)90789-1. [DOI] [PubMed] [Google Scholar]
  9. Linos A., Worthington J. W., O'Fallon W. M., Kurland L. T. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol. 1980 Jan;111(1):87–98. doi: 10.1093/oxfordjournals.aje.a112878. [DOI] [PubMed] [Google Scholar]
  10. Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Royal College of General Practitioners' Oral Contraception Study. Lancet. 1978 Mar 18;1(8064):569–571. [PubMed] [Google Scholar]
  11. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  12. Spector T. D., Hochberg M. C. The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis. J Clin Epidemiol. 1990;43(11):1221–1230. doi: 10.1016/0895-4356(90)90023-i. [DOI] [PubMed] [Google Scholar]
  13. Thompson P. W., Silman A. J., Kirwan J. R., Currey H. L. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum. 1987 Jun;30(6):618–623. doi: 10.1002/art.1780300603. [DOI] [PubMed] [Google Scholar]
  14. van den Brink H. R., Lems W. F., van Everdingen A. A., Bijlsma J. W. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis. 1993 Apr;52(4):302–305. doi: 10.1136/ard.52.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. van den Brink H. R., van der Heide A., Jacobs J. W., van der Veen M. J., Bijlsma J. W. Evaluation of the Thompson articular index. J Rheumatol. 1993 Jan;20(1):28–32. [PubMed] [Google Scholar]
  16. van der Heide A., Jacobs J. W., Dinant H. J., Bijlsma J. W. The impact of endpoint measures in rheumatoid arthritis clinical trials. Semin Arthritis Rheum. 1992 Apr;21(5):287–294. doi: 10.1016/0049-0172(92)90022-6. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES